Back
Day Range
$34.39
$34.39
52-Week Range
$6.98
$34.39
Volume
21,644
50D / 200D Avg
$13.01
/
$8.48
Prev Close
$34.39
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -67.0 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.8 |
| Net Margin % | -72.2 | 3.9 |
| Rev Growth 5Y % | 32.9 | 10.0 |
| D/E | — | 0.2 |
Key Takeaways
Revenue grew 32.91% annually over 5 years — strong growth
Generating 17.81M in free cash flow
PEG of 0.36 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 145.92%
Capital efficient — spends only 6.50% of revenue on capex
Growth
Revenue Growth (5Y)
32.91%
Revenue (1Y)178.83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-19.18%
Net Margin-72.19%
Op. Margin-42.44%
Safety
Debt / Equity
N/A
Current Ratio2.70
Interest Coverage-2.13
Valuation
P/E Ratio
-66.97
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 178.83% | Revenue Growth (3Y) | 60.26% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 32.91% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 25.54M | Net Income (TTM) | -18.44M |
| ROE | N/A | ROA | -20.38% |
| Gross Margin | 100.00% | Operating Margin | -42.44% |
| Net Margin | -72.19% | Free Cash Flow (TTM) | 17.81M |
| ROIC | -19.18% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 2.70 |
| Interest Coverage | -2.13 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -66.97 | P/B Ratio | N/A |
| P/S Ratio | 48.34 | PEG Ratio | 0.36 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.23B | Enterprise Value | 1.23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25.54M | 9.16M | 9.94M | 4.09M | 8.19M |
| Net Income | -18.44M | -25.04M | -32.01M | -24.81M | -19.02M |
| EPS (Diluted) | -0.63 | -0.88 | -1.27 | -1.00 | -0.86 |
| Gross Profit | 25.54M | 9.16M | 9.94M | 4.09M | 6.74M |
| Operating Income | -10.84M | -20.98M | -24.03M | -23.81M | -15.61M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 90.45M | 36.95M | 29.34M | 44.30M | 63.61M |
| Total Liabilities | 106.82M | 77.77M | 71.63M | 57.67M | 54.69M |
| Shareholders' Equity | -16.37M | -40.82M | -42.29M | -13.37M | 8.92M |
| Total Debt | 58.76M | 58.96M | 57.71M | 47.49M | 43.35M |
| Cash & Equivalents | 59.04M | 19.46M | 6.47M | 24.62M | 47.10M |
| Current Assets | 80.62M | 27.26M | 19.57M | 34.07M | 56.33M |
| Current Liabilities | 29.87M | 16.47M | 57.03M | 38.24M | 13.60M |